French Supreme Court - Biogaran v. the MSD/Organon companies
Decision date
2025-08-31
Nature
Patent
Country
France
Jurisdiction
French Supreme Court
Parties
Biogaran v. the MSD/Organon companies
Representation of Biogaran against the MSD/Organon companies in PI proceedings relating to the French SPC protecting the combination of Ezetimibe and Simvastatin, resulting in the final invalidation of the SPC and the final dismissal of MSD/Organon’s application for a preliminary injunction following its withdrawal before the French Supreme Court.
Biogaran was represented by Marianne Gabriel attorney-at-law at the Paris Bar.

